CTPNV:EURONEXT AMSTERDAMCTP N.V. Analysis
Data as of 2026-07-16 - not real-time
€16.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CTP N.V. trades at €16.20, precisely at its calculated resistance of €16.20 and just above the 20‑day SMA of €15.87, while still lagging the 200‑day SMA of €17.56, indicating short‑term momentum but a longer‑term bearish bias. The MACD histogram is positive (0.06) and the signal line is bullish, yet the RSI sits at 68, bordering overbought territory, suggesting a potential pull‑back toward the support level of €15.54. Valuation metrics are compelling: the trailing P/E of 7.07 is far below the industry average of 32, and the P/B of 0.90 signals a discount to book value, positioning the stock as undervalued. Dividend yield is attractive at 3.95% with a modest payout ratio of 26%, supporting the case for income‑focused investors. However, the balance sheet is heavily leveraged, with €9.4 bn of debt versus €0.63 bn of cash (debt‑to‑equity ≈ 108%), and free cash flow is modest at €64 m, flagging financial risk. Volatility over the past 30 days is elevated at 21.5% and the beta of 0.16 points to low market‑beta exposure but heightened idiosyncratic risk. Recent regulatory filings confirm dividend scrip take‑up and an upcoming H1‑2026 results release, underscoring a stable corporate governance environment. Overall, the stock presents a mix of strong valuation and dividend appeal against a backdrop of high leverage and sector cyclicality.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price at technical resistance and high RSI
- Elevated short‑term volatility
- High leverage raising downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to peers
- Attractive dividend yield with low payout ratio
- Strong operating margins and cash generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term demand for logistics and industrial real estate
- Sustainability credentials (BREEAM, ESG rating)
- Consistent dividend policy despite leverage
Key Metrics & Analysis
Financial Health
Revenue Growth13.90%
Profit Margin109.46%
P/E Ratio7.1
ROE13.49%
ROA2.18%
Debt/Equity108.35
P/B Ratio0.9
Op. Cash Flow€298.2M
Free Cash Flow€64.4M
Industry P/E32.0
Technical Analysis
TrendBearish
RSI68.2
Support€15.54
Resistance€16.20
MA 20€15.87
MA 50€16.07
MA 200€17.56
MACDBullish
VolumeStable
Fear & Greed Index93.45
Valuation
GradeUndervalued
TypeValue
Dividend Yield3.95%
Risk Assessment
Beta0.16
Volatility21.48%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.